Covalon Technologies (CVE:COV) Shares Down 1.6% – What’s Next?

Shares of Covalon Technologies Ltd. (CVE:COV) fell 1.6% during mid-day trading on Monday . The company traded as low as C$1.76 and last traded at C$1.80. 482 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 14,073 shares. The stock had previously closed at C$1.83.

Covalon Technologies Price Performance

The company has a current ratio of 5.69, a quick ratio of 6.45 and a debt-to-equity ratio of 7.82. The firm has a market capitalization of C$49.71 million, a price-to-earnings ratio of 60.00 and a beta of 1.01. The company’s 50 day moving average is C$1.73 and its 200-day moving average is C$1.87.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.